Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The neural correlates of guilt highlight preclinical manifestations between bipolar and major depressive disorders.

Comprehensive psychiatry·2024

Same author

Panic Disorder Correlates With the Risk for Sexual Dysfunction.

Journal of psychiatric practice·2020

Same author

Severity in sustained attention impairment and clozapine-resistant schizophrenia: a retrospective study.

BMC psychiatry·2019

Same author

Prevalence and Predictors of Metabolic Syndrome in People With Schizophrenia in Inpatient Rehabilitation Wards.

Biological research for nursing·2016

Search research articles

Related Experiment Video

Updated: Feb 28, 2026

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

Amisulpride withdrawal dyskinesia: a case report.

Yu-Chi Lo¹, Ying-Chieh Peng²

¹Ministry of Health and Welfare Kinmen Hospital, No. 2, Fuxing Rd., Jinhu Township, Kinmen County, 89142 Taiwan.

Annals of General Psychiatry

|June 21, 2017

Summary

Antipsychotic drug withdrawal, particularly amisulpride, can cause withdrawal dyskinesia. Prompt identification and intervention are crucial to manage these abnormal involuntary movements and prevent persistent tardive dyskinesia.

Keywords:

Abnormal involuntary movement Amisulpride Antipsychotics Case report Dyskinesia Schizophrenia Side effects Withdrawal

More Related Videos

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis

Published on: November 21, 2013

Related Experiment Videos

Last Updated: Feb 28, 2026

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis

Published on: November 21, 2013

Area of Science:

Neuroscience
Psychopharmacology

Background:

Antipsychotic drug withdrawal effects are understudied.
Limited research exists on amisulpride withdrawal dyskinesia.

Observation:

A 63-year-old male with schizophrenia experienced severe withdrawal dyskinesia, dystonia, and akathisia after amisulpride dosage reduction.
Symptoms improved upon increasing the amisulpride dosage.

Findings:

Dosage reduction or abrupt cessation of amisulpride can precipitate withdrawal dyskinesia.
Withdrawal-emergent dyskinesia may evolve into persistent tardive dyskinesia.

Implications:

Early identification of withdrawal-emergent dyskinesia is essential.
Prompt medical intervention can manage abnormal involuntary movements.
Understanding amisulpride withdrawal is critical for patient care.